These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 16956865

  • 1. Adolescent and young adult heroin patients: drug use and success in methadone maintenance treatment.
    Kellogg S, Melia D, Khuri E, Lin A, Ho A, Kreek MJ.
    J Addict Dis; 2006; 25(3):15-25. PubMed ID: 16956865
    [Abstract] [Full Text] [Related]

  • 2. Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program.
    Maremmani I, Pani PP, Mellini A, Pacini M, Marini G, Lovrecic M, Perugi G, Shinderman M.
    J Addict Dis; 2007; 26(1):61-70. PubMed ID: 17439869
    [Abstract] [Full Text] [Related]

  • 3. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B, Blake J, Marsh DC, Sproule B, Jeyapalan R, Li S.
    J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
    [Abstract] [Full Text] [Related]

  • 4. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
    Peles E, Schreiber S, Adelson M.
    Drug Alcohol Depend; 2010 Mar 01; 107(2-3):141-8. PubMed ID: 19914783
    [Abstract] [Full Text] [Related]

  • 5. Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users.
    Bravo MJ, Llorens N, Barrio G, Brugal MT, Santos S, Sordo L, de la Fuente L, Itinere Project Group.
    Drug Alcohol Depend; 2010 Nov 01; 112(1-2):62-8. PubMed ID: 20591582
    [Abstract] [Full Text] [Related]

  • 6. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K.
    J Psychiatr Pract; 2009 May 01; 15(3):227-34. PubMed ID: 19461397
    [Abstract] [Full Text] [Related]

  • 7. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
    Kerr T, Marsh D, Li K, Montaner J, Wood E.
    Drug Alcohol Depend; 2005 Dec 12; 80(3):329-35. PubMed ID: 15964714
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM.
    Addiction; 2009 May 12; 104(5):775-83. PubMed ID: 19344438
    [Abstract] [Full Text] [Related]

  • 12. Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands.
    Blanken P, Hendriks VM, van Ree JM, van den Brink W.
    Addiction; 2010 Feb 12; 105(2):300-8. PubMed ID: 19922517
    [Abstract] [Full Text] [Related]

  • 13. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M, McIntosh J, McKeganey N, Robertson M.
    Public Health; 2008 Oct 12; 122(10):1013-9. PubMed ID: 18490036
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, Callaman JM, O'Grady KE, Battjes RJ.
    Arch Gen Psychiatry; 2006 Jan 12; 63(1):102-9. PubMed ID: 16389204
    [Abstract] [Full Text] [Related]

  • 15. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M, Ross J, Darke S, Lynskey M, Ali R, Ritter A, Cooke R.
    Drug Alcohol Depend; 2006 Jun 28; 83(2):174-80. PubMed ID: 16343809
    [Abstract] [Full Text] [Related]

  • 16. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, Gerra ML, Amore M, Manfredini M, Donnini C, Somaini L.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):483-9. PubMed ID: 21147192
    [Abstract] [Full Text] [Related]

  • 17. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P, Guglielmino L, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L, Cozzolino E.
    J Subst Abuse Treat; 2006 Jul 30; 31(1):3-7. PubMed ID: 16814005
    [Abstract] [Full Text] [Related]

  • 18. Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.
    Verthein U, Haasen C, Reimer J.
    Subst Use Misuse; 2011 Jul 30; 46(8):980-91. PubMed ID: 21235340
    [Abstract] [Full Text] [Related]

  • 19. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.
    Longshore D, Annon J, Anglin MD, Rawson RA.
    Addiction; 2005 Aug 30; 100(8):1131-9. PubMed ID: 16042643
    [Abstract] [Full Text] [Related]

  • 20. Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study.
    Baumeister M, Vogel M, Dürsteler-MacFarland KM, Gerhard U, Strasser J, Walter M, Wiesbeck GA, Petitjean SA.
    Subst Abuse Treat Prev Policy; 2014 Dec 04; 9():46. PubMed ID: 25472871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.